Upsher-Smith debuts generic Apriso
Apriso is indicated for the maintenance of remission of ulcerative colitis in adults.
Upsher-Smith is offering mesalamine extended-release capsules, 375 mg, which is the generic of Salix Pharmaceuticals’ Apriso.
Apriso is indicated for the maintenance of remission of ulcerative colitis in adults.
The mesalamine capsule had a market value of approximately $105 million for the 12 months ending June 2023, per IQVIA.